Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand

2017 ◽  
Vol 42 (3) ◽  
pp. 337-344 ◽  
Author(s):  
P. Tanvejsilp ◽  
E. Pullenayegum ◽  
M. Loeb ◽  
J. Dushoff ◽  
F. Xie

Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) screened for eligibility, seventy-six patients enrolled in the study and randomly allocated into two groups: pharmaceutical care and usual care, both groups interviewed by the pharmacist using specific questionnaire for assessing the quality of life (QoL). All the drug related problems (DRPs) including drug-drug interactions (DDIs) were recorded by the pharmacist. Blood samples were collected and utilized for analyzing the levels of vitamin D, phosphorous, calcium, albumin and parathyroid hormone at baseline and three months after. The pharmaceutical care group received all the educations about their medications and how to minimize DRPs; improve the QoL. Additionally, the pharmaceutical intervention included correcting the biochemical parameters. Results: Pharmaceutical care significantly improved patients QoL and minimized DRPs and DDIs. It was also effective in improving the biochemical parameters. Conclusion: Pharmaceutical care has a positive impact on improving the outcome of patients with CKD-MBD through attenuating DRPs, improving the biochemical parameters and the QoL.


Author(s):  
Chandramouli M.T

AbstractLife-threatening adverse reactions of antitubercular drugs are uncommon; however, thrombocytopenia is one such rare complication encountered with rifampicin, isoniazid, ethambutol, and pyrazinamide. Rifampicin is the most effective drug and its use in the tuberculosis treatment led to the emergence of modern and effective short-course regimens. I am reporting case series of three patients with pulmonary tuberculosis presented with rifampicin-induced thrombocytopenia.


1994 ◽  
Vol 75 ◽  
pp. 29
Author(s):  
A. McDaniel ◽  
N. Schoenfeld ◽  
W. Frank ◽  
A. Grassot ◽  
H. Mauch ◽  
...  

CHEST Journal ◽  
1992 ◽  
Vol 101 (5) ◽  
pp. 1211-1214 ◽  
Author(s):  
Adelaida M. Miro ◽  
Eugene Gibilara ◽  
Steven Powell ◽  
Stephan L. Kamholz

2003 ◽  
Vol 47 (4) ◽  
pp. 317-321 ◽  
Author(s):  
David Bell ◽  
Vicky Leckie ◽  
Mike McKendrick

2015 ◽  
Vol 56 (2) ◽  
pp. 340
Author(s):  
Doosoo Jeon ◽  
Seung Eun Lee ◽  
Woo Hyun Cho ◽  
Byung Hee Lee ◽  
Yun Seong Kim ◽  
...  

1993 ◽  
Vol 16 (1) ◽  
pp. 41
Author(s):  
Nancy Shields ◽  
S. H. Salzman ◽  
M. L. Schindel ◽  
C. P. Aranda ◽  
R. L. Smith ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0207404
Author(s):  
Gokul Raj Kathamuthu ◽  
Kadar Moideen ◽  
Vaithilingam V. Banurekha ◽  
Dina Nair ◽  
R. Sridhar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document